Ratings by Aegis Capital (David Bouchey)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/18/2025 | Sunshine Biopharma Inc. | SBFM | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2025 | Sunshine Biopharma Inc. | SBFM | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Sunshine Biopharma Inc. | SBFM | New Coverage | Buy (N/A) |
0.49 (1.11) |
126.53% | Details | |
| 5/9/2023 | Sharps Technology, Inc. | STSS | New Coverage | Buy (N/A) |
0.80 (1.79) |
123.75% | Details | |
| 3/6/2023 | Avenue Therapeutics | ATXI | New Coverage | Buy (N/A) |
1.06 (0.42) |
-60.38% | Details |
